| Literature DB >> 35407650 |
Ahmed Alalawi1,2, Valter Devecchi2, Alessio Gallina2, Alejandro Luque-Suarez3,4, Deborah Falla2.
Abstract
The aim of this study was to examine for the presence of differences in neuromuscular and psychological function in individuals with recurrent neck pain (RNP) or chronic neck pain (CNP) following a whiplash trauma compared to healthy controls. A secondary aim was to examine whether neuromuscular characteristics together with psychological features in people with RNP were predictive of future painful episodes. Multiple features were assessed including neck disability, kinesiophobia, quality of life, cervical kinematics, proprioception, activity of superficial neck flexor muscles, maximum neck flexion and extension strength, and perceived exertion during submaximal contractions. Overall, those with RNP (n = 22) and CNP (n = 8) presented with higher neck disability, greater kinesiophobia, lower quality of life, slower and irregular neck movements, and less neck strength compared to controls (n = 15). Prediction analysis in the RNP group revealed that a higher number of previous pain episodes within the last 12 months along with lower neck flexion strength were predictors of higher neck disability at a 6-month follow-up. This preliminary study shows that participants with RNP presented with some degree of altered neuromuscular features and poorer psychological function with respect to healthy controls and these features were similar to those with CNP. Neck flexor weakness was predictive of future neck disability.Entities:
Keywords: cervical kinematics; chronic neck pain; neuromuscular function; recurrent neck pain; whiplash
Year: 2022 PMID: 35407650 PMCID: PMC8999485 DOI: 10.3390/jcm11072042
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flowchart of study population.
Summary of collected data across groups and their time points.
| Data Collection Point | Domain | Variables | RNP | CNP | Healthy Controls |
|---|---|---|---|---|---|
| Baseline | Demographics | Age | ✓ | ✓ | ✓ |
| Gender | ✓ | ✓ | ✓ | ||
| Height | ✓ | ✓ | ✓ | ||
| Weight | ✓ | ✓ | ✓ | ||
| Patient-reported measures | NDI | ✓ | ✓ | ✓ | |
| TSK-11 | ✓ | ✓ | ✓ | ||
| EQ-5D | ✓ | ✓ | ✓ | ||
| Others | Number of neck pain episodes | ✓ | |||
| Average of pain episodes (VAS) | ✓ | ||||
| Neck pain duration | ✓ | ||||
| Current pain intensity | ✓ | ||||
| Objective measures | Cervical kinematics (RoM, velocity, and smoothness) | ✓ | ✓ | ✓ | |
| Neck proprioception | ✓ | ✓ | ✓ | ||
| Peak score of craniocervical flexion test | ✓ | ✓ | ✓ | ||
| Muscle activity during submaximal CCF contractions | ✓ | ✓ | ✓ | ||
| Maximum neck strength in flexion and extension (MVC flexion and extension [kg]) | ✓ | ✓ | ✓ | ||
| Perceived exertion during the submaximal task in flexion and extension (Borg’s scale) | ✓ | ✓ | ✓ | ||
| Outcome measures | Questionnaires | Number of days with pain | ✓ | ||
| Neck Disability Index (NDI) | ✓ |
RNP: recurrent neck pain; CNP: chronic neck pain; ✓: collected data.
Baseline characteristics of all three groups.
| Groups | ||||
|---|---|---|---|---|
| Healthy Control | RNP | CNP | ||
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Age (years) | 31.1 ± 5.7 | 31.0 ± 11.8 | 33.6 ± 8.7 | 0.24 1 |
| Gender (male:female (%)) | 6:9 (60%) | 8:14 (64%) | 1:7 (88%) | 0.38 2 |
| Height (m) | 1.7 ± 0.1 | 1.7 ± 0.1 | 1.6 ± 0.1 | 0.02 3 |
| Weight (kg) | 69.1 ± 14.8 | 74.7 ± 18.0 | 59.5 ± 9.8 | 0.07 1 |
| NDI (0–50) | 0.7 ± 1.1 | 5.5 ± 3.2 * | 17.5 ± 7.6 * | <0.001 1 |
| TSK (17–68) | 29.1 ± 4.3 | 35.2 ± 5.5 * | 40.5 ± 7.5 * | <0.001 3 |
| EQ-5D (0–1) | 0.98 ± 0.04 | 0.92 ± 0.09 * | 0.68 ± 0.21 *,† | <0.001 1 |
| EQ VAS (0–100) | 85.5 ± 10.2 | 78.5 ± 15.4 | 64.1 ± 14.4 *,† | 0.005 1 |
| Number of pain episodes, 12 m | - | 5.9 ± 4.4 | - | |
| Average of pain episodes, VAS (0–100) | - | 56.4 ± 14.5 | - | |
| Current neck pain, VAS (0–100) | - | - | 56.1 ± 19.5 | |
| Neck pain duration, m | - | - | 39.1 ± 41.4 | |
SD: standard deviation; NDI: Neck Disability Index; TSK: Tampa Scale of Kinesiophobia; EQ-5D: European Quality of Life—5 Dimensions; EQ-VAS; self-rated health on a vertical visual analogue scale; VAS: Visual Analogue Scale. 1 Kruskal–Wallis Test. 2 Chi-square Test. 3 One-way ANOVA (Bonferroni post hoc shows significant group difference in height between healthy and CNP [p < 0.02], and RNP and CNP [p < 0.03]). * Post hoc significant difference from control group at p < 0.05. † Post hoc significant difference from RNP group at p < 0.05.
Summary statistics for the kinematic and proprioception features of all three groups with differences assessed using One-way ANOVA.
| Groups | ||||
|---|---|---|---|---|
| Healthy Control | RNP | CNP | ||
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Flexion | ||||
| Vmean (°/s) | 72.8 ± 12.3 | 55.0 ± 18.5 * | 42.9 ± 14.3 * | 0.002 1 |
| Vpeak (°/s) | 149.5 ± 33.9 | 114.0 ± 41.3 * | 90.8 ± 28.8 * | 0.004 |
| NVP ( | 9.4 ± 4.0 | 17.1 ± 9.4 * | 17.5 ± 8.2 | 0.005 2 |
| Extension | ||||
| Vmean (°/s) | 66.5 ± 15.7 | 55.4 ± 21.2 | 46.7 ± 16.5 | 0.09 1 |
| Vpeak (°/s) | 133.8 ± 31.5 | 111.0 ± 45.1 | 97.2 ± 34.4 | 0.12 |
| NVP ( | 8.3 ± 4.1 | 17.8 ± 14.0 | 16.5 ± 9.0 | 0.066 1 |
| Right Rotation | ||||
| Vmean (°/s) | 132.5 ± 29.3 | 101.5 ± 41.7 * | 82.5 ± 22.0 * | 0.001 2 |
| Vpeak (°/s) | 244.7 ± 52.5 | 190.5 ± 76.7 | 157.1 ± 37.9 * | 0.001 2 |
| NVP ( | 5.1 ± 3.3 | 8.6 ± 9.1 | 10.2 ± 6.5 | 0.017 1 |
| JPE | 3.8 ± 2.1 | 4.4 ± 2.5 | 5.5 ± 5.9 * | 0.76 1 |
| Left Rotation | ||||
| Vmean (°/s) | 131.2 ± 30.7 | 100.1 ± 41.0 * | 79.5 ± 22.6 * | 0.001 2 |
| Vpeak (°/s) | 244.5 ± 57.2 | 188.8 ± 71.7 * | 148.7 ± 34.7 * | <0.001 2 |
| NVP ( | 3.7 ± 2.8 | 9.0 ± 8.8 | 11.6 ± 10.5 | 0.014 1 |
| JPE | 4.2 ± 2.8 | 4.7 ± 2.8 * | 5.2 ± 5.2 * | 0.711 1 |
| Combined RoM | ||||
| Flexion/Extension | 52.6 ± 8.1 | 49.5 ± 7.9 | 42.9 ± 10.2 * | 0.041 |
| Right/Left Rotations | 71.5 ± 6.2 | 67.1 ± 9.4 | 62.1 ± 9.1 * | 0.042 |
SD: standard deviation; SD error: Standard error (of the mean); CI: confidence intervals; RoM: Range of motion; Vmean: mean velocity; Vpeak: peak velocity; Vpeaks: mean of peaks velocity; NVP: number of velocity peaks; JPE: joint position error. 1 Differences were assessed using Kruskal–Wallis ANOVA. 2 Differences were assessed using Welch’s ANOVA. * Post hoc significant difference from control group at p < 0.05.
Normalized EMG amplitude (%) recorded from sternocleidomastoid muscles during each of the five submaximal craniocervical flexion contractions in addition to the maximum craniocervical contraction.
| Groups | ||||
|---|---|---|---|---|
| Healthy Control | RNP | CNP | ||
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Normalized EMG amplitude (%) | ||||
| 20% | 18.8 ± 12.0 | 33.6 ± 22.6 | 52.0 ± 53.1 | 0.11 1 |
| 40% | 35.2 ± 23.9 | 64.3 ± 88.5 | 70.8 ± 36.5 | 0.07 1 |
| 60% | 50.9 ± 15.9 | 58.7 ± 29.0 | 111.8 ± 80.1 *,† | 0.003 |
| 80% | 66.9 ± 21.7 | 79.0 ± 33.6 | 108.6 ± 88.4 | 0.34 1 |
| Maximum craniocervical contraction | ||||
| CCF MVC (N) | 52.1 ± 22.3 | 44.0 ± 23.4 | 47.1 ± 22.8 | 0.57 |
SD: standard deviation; SD error: standard error (of the mean); CI: confidence intervals, CCF MVC: maximum craniocervical flexion strength; N: Newton (unit of force). Numbers are presented as normalized EMG (%). 1 Kruskal–Wallis ANOVA. * Post hoc significant difference from control group at p < 0.05. † Post hoc significant difference from RNP group at p < 0.05.
Results of neck strength during the isometric contraction and perceived fatigue during submaximal contraction in MCU.
| Groups | ||||
|---|---|---|---|---|
| Healthy Control | RNP | CNP | ||
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Maximal strength (MVC) | ||||
| Flexion MVC (kg) | 20.2 ± 9.7 | 14.6 ± 6.4 | 15.3 ± 3.1 | 0.17 1 |
| Extension MVC (kg) | 29.6 ± 18.5 | 15.3 ± 4.4 * | 21.6 ± 9.1 | 0.006 1 |
| Rate of perceived exertion (BORG scale: 6–20) | ||||
| Flexion Borg (6–20) | 12.0 ± 3.1 | 15.0 ± 3.0 * | 14.7 ± 1.7 | 0.01 |
| Extension Borg (6–20) | 8.9 ± 2.5 | 9.9 ± 2.5 | 10.4 ± 2.6 | 0.38 1 |
SD: standard deviation; SD error: standard error (of the mean); CI: confidence intervals; MVC: maximal voluntary contraction. 1 Kruskal–Wallis ANOVA. * Post hoc significant difference from control group at p < 0.05.
Selected predictor variables for response variable of number of days with pain.
| NDI at 6 Months | Number of Days with Pain | |
|---|---|---|
| (Intercept) | 8.65 | 4.68 |
| NDI | 0 | 0 |
| TSK | 0 | 0 |
| EQ-VAS | 0 | 0 |
| EQ-5D | 0 | 0 |
| Previous number of pain episodes | 0.68 | 0.57 |
| Average of pain episodes | 0 | 0 |
| ROM in flexions and extension | 0 | 0 |
| ROM in rotations | 0 | 0 |
| NVP in flexions and extension | 0 | 0 |
| JPE | 0 | 0 |
| 20% and 40 of CCF MVC force | 0 | 0 |
| 60%, and 80% of CCF MVC force | 0 | 0 |
| CCF MVC | 0 | 0 |
| MVC during cervical flexion | −0.34 | 0 |
| MVC during cervical extension | 0 | 0 |
NDI: Neck Disability Index; TSK: Tampa Scale of Kinesiophobia; EQ-5D: European Quality of Life—5 Dimensions; EQ-VAS; self-rated health on a vertical visual analogue scale; RoM: range of motion; NVP: number of velocity peaks; JPE: joint position error; CCF MVC: maximum craniocervical flexion strength; MVC: maximal voluntary contraction.
Results of multivariate regression analysis showing associations between baseline predictors and NDI at six months.
| β | SE | Low 95%CI | Upper 95% CI | Adjusted R2 | |||
|---|---|---|---|---|---|---|---|
| (Intercept) | 10.23 | 2.99 | 3.42 | 0.004 | 3.82 | 16.63 | 0.43 |
| MVC flexion | −0.32 | 0.15 | −2.21 | 0.04 | −0.64 | −0.01 | |
| Previous number of pain episodes | 0.54 | 0.21 | 2.56 | 0.02 | 0.09 | 0.99 |
β: unstandardized coefficient; SE: standard error; CI: confidence interval; Adjusted R2: represents the variance in NDI (the outcome) as explained by the variables; MVC: maximum voluntary contraction. n = 19; 86% with complete cases
Figure 2Scatterplots of two models fit comparing the predicted and observed values for each outcome: NDI: Neck Disability Index at six months (A) and number of days with pain over the 12-month follow-up period (B). The diagonal line in red indicates perfect prediction. RMSE: root mean square error, which represents the error between predicted and observed values in each generated prognostic model. Lower values of RMSE indicate better prediction.
Results of multivariate regression analysis showing associations between baseline predictors and number of days with pain (average of 12 months).
| β | SE | Low 95%CI | Upper 95% CI | Adjusted R2 | |||
|---|---|---|---|---|---|---|---|
| (Intercept) | 2.14 | 1.17 | 1.83 | 0.08 | −0.33 | 4.61 | 0.25 |
| Previous number of pain episodes | 0.40 | 0.15 | 2.63 | 0.02 | 0.08 | 0.71 |
β: unstandardized coefficient; SE: standard error; CI: confidence interval; Adjusted R2: represents the variance in number of days with pain (the outcome) as explained by the variable. n = 17; 77% with complete cases.